Actively Recruiting
Oral Immunotherapy for Egg Allergy in Children Aged 6 to 16
Led by Tampere University Hospital · Updated on 2024-04-10
60
Participants Needed
2
Research Sites
365 weeks
Total Duration
On this page
Sponsors
T
Tampere University Hospital
Lead Sponsor
U
University of Oulu
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim of the study is to determine the efficacy of a 12-month egg oral immunotherapy (OIT) protocol with a cooked whole egg product including yolk and egg white. Study hypothesis: With this method the risk for severe allergic reaction to egg protein is reduced and the diet can partly or completely be normalized.
CONDITIONS
Official Title
Oral Immunotherapy for Egg Allergy in Children Aged 6 to 16
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 6 to 16 years
- Elevated specific serum IgE to egg (> 5 kU/l) and/or positive skin prick test to egg allergen
- Positive oral food challenge for egg or anaphylaxis reaction to egg within the last 6 months
- Diet free from egg in any form
You will not qualify if you...
- Age less than 6 years or more than 16 years
- Poor asthma control or uncontrolled asthma
- Severe or significant cardiovascular disease
- Autoimmune disease
- Malignancy
- Use of beta blockers, ACE inhibitors, or MAO inhibitors
- Poor compliance
- Fear of immunotherapy
- Desensitization to alfa-gal-protein (mammalian meat allergy)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Oulu University Hospital
Oulu, Finland, 90230
Actively Recruiting
2
Tampere University Hospital
Tampere, Finland, 33520
Actively Recruiting
Research Team
R
Rüdiger Schultz, MD., PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here